You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
青海華鼎(600243.SH)完成轉讓千醫百順100%股權
格隆匯 12-31 17:34

格隆匯12月31日丨青海華鼎(600243.SH)公佈,公司於2019年12月6日召開的第七屆董事會第十四次會議和於2019年12月23日召開的公司2019年第二次臨時股東大會審議通過了《關於處置子公司股權的議案》。同意以公開交易方式擬對全資子公司千醫百順100%股權和控股子公司廣東中龍51%股權予以處置。經審計,截止2019年9月30日,千醫百順和廣東中龍財務數據的賬面淨資產均為負值,則處置價格均定為0元。

2019年12月31日,公司收到廣州產權交易所出具的《產權交易憑證》,上述資產在掛牌期內,經廣州產權交易所確認千醫百順只產生一家符合條件的受讓方,受讓方為自然人伍梓妍,報價為1.00元,公司與受讓方伍梓妍簽訂了《千醫百順股權轉讓合同》。處置廣東中龍51%股權尚未徵得到意向方。

2019年12月31日,千醫百順在廣州市番禺區市場監督管理局已完成本次股權轉讓的工商變更登記手續,並取得新的《營業執照》。

千醫百順工商變更後,公司不再持有千醫百順股權,千醫百順不再納入公司合併報表範圍內。經財務部門初步測算,處置千醫百順100%股權對上市公司合併財務報表淨利潤的綜合影響約-600萬元,最終損益以經審計機構確認後披露的公司2019年度審計報告為準。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account